Tyra Biosciences (TYRA) Current Assets (2020 - 2026)

Quarterly Current Assets rose 21.58% to $394.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $394.6 million through Mar 2026, up 21.58% year-over-year, with the annual reading at $265.4 million for FY2025, 23.6% down from the prior year.

Tyra Biosciences filings provide 7 years of Current Assets readings, the most recent being $394.6 million for Q1 2026.

  • Current Assets hit $394.6 million in Q1 2026 for Tyra Biosciences, up from $265.4 million in the prior quarter.
  • Across five years, Current Assets topped out at $394.6 million in Q1 2026 and bottomed at $211.7 million in Q4 2023.
  • Average Current Assets over 5 years is $298.3 million, with a median of $281.2 million recorded in 2025.
  • The largest annual shift saw Current Assets surged 64.15% in 2024 before it decreased 23.6% in 2025.
  • Tyra Biosciences' Current Assets stood at $257.3 million in 2022, then dropped by 17.73% to $211.7 million in 2023, then surged by 64.15% to $347.5 million in 2024, then dropped by 23.6% to $265.4 million in 2025, then skyrocketed by 48.66% to $394.6 million in 2026.
  • Per Business Quant, the three most recent readings for TYRA's Current Assets are $394.6 million (Q1 2026), $265.4 million (Q4 2025), and $281.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 10.37 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 37.31 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 1.25 Bn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 73.04 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 3.59 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 11.73 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 18.21 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 4.22 Bn
10 Tyra Biosciences 2.03 Bn 2.03 Bn - 394.61 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 394.61 Mn
Dec 31, 2025 265.45 Mn
Sep 30, 2025 281.22 Mn
Jun 30, 2025 302.16 Mn
Mar 31, 2025 324.57 Mn
Dec 31, 2024 347.46 Mn
Sep 30, 2024 365.61 Mn
Jun 30, 2024 378.57 Mn
Mar 31, 2024 390.78 Mn
Dec 31, 2023 211.67 Mn
Sep 30, 2023 224.63 Mn
Jun 30, 2023 240.75 Mn
Mar 31, 2023 246.71 Mn
Dec 31, 2022 257.29 Mn
Sep 30, 2022 267.47 Mn
Jun 30, 2022 277.30 Mn
Mar 31, 2022 294.03 Mn
Dec 31, 2021 304.06 Mn
Sep 30, 2021 313.50 Mn
Dec 31, 2020 15.28 Mn